4.6 Article

High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Respiratory System

Comparison of the treatment guidelines for sarcoidosis: common sense in the search for evidence

Vivienne Kahlmann et al.

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Medicine, General & Internal

Diagnosis and Treatment of Pulmonary Sarcoidosis A Review

John A. Belperio et al.

Summary: Sarcoidosis is an inflammatory granulomatous disease that affects 2 to 160 people per 100,000 worldwide and can involve any organ. Approximately 10% to 30% of patients with pulmonary sarcoidosis develop progressive disease, and over 60% of deaths are due to advanced pulmonary sarcoidosis.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Respiratory System

BTS Clinical Statement on pulmonary sarcoidosis

Muhunthan Thillai et al.

THORAX (2021)

Article Respiratory System

ERS clinical practice guidelines on treatment of sarcoidosis

Robert P. Baughman et al.

Summary: Treatment of sarcoidosis aims to reduce morbidity and mortality risk, and improve quality of life. Various treatments are available, with decisions based on organ involvement, risk assessment, and impact on quality of life.

EUROPEAN RESPIRATORY JOURNAL (2021)

Review Respiratory System

Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis

Aman Pande et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)

Review Respiratory System

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis

Franck F. Rahaghi et al.

EUROPEAN RESPIRATORY REVIEW (2020)

Editorial Material Cardiac & Cardiovascular Systems

Steroids for sarcoidosis: How much and for how long?

Robert P. Baughman et al.

RESPIRATORY MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis

Caroline E. Broos et al.

RESPIRATORY MEDICINE (2018)

Review Critical Care Medicine

Pulmonary sarcoidosis

Paolo Spagnolo et al.

LANCET RESPIRATORY MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

Toxicity risk from glucocorticoids in sarcoidosis patients

Nauman A. Khan et al.

RESPIRATORY MEDICINE (2017)

Article Rheumatology

Corticosteroids in Sarcoidosis

Marc A. Judson

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)

Article Cardiac & Cardiovascular Systems

The effect of corticosteroids on quality of life in a sarcoidosis clinic: The results of a propensity analysis

Marc A. Judson et al.

RESPIRATORY MEDICINE (2015)

Review Critical Care Medicine

New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches

Robert P. Baughman et al.

LANCET RESPIRATORY MEDICINE (2015)

Editorial Material Respiratory System

Negative clinical trials in sarcoidosis: failed therapies or flawed study design?

David R. Moller

EUROPEAN RESPIRATORY JOURNAL (2014)

Editorial Material Respiratory System

Relapses of sarcoidosis: what are they and can we predict who will get them?

Robert P. Baughman et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Article Medicine, General & Internal

Sarcoidosis

Dominique Valeyre et al.

LANCET (2014)

Article Cardiac & Cardiovascular Systems

Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis

Willemien P. E. de Kleijn et al.

RESPIRATORY MEDICINE (2011)

Article Medicine, General & Internal

Efficacy of Short-Course, Low-Dose Corticosteroid Therapy for Acute Pulmonary Sarcoidosis Exacerbations

Brian P. McKinzie et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)

Review Respiratory System

Corticosteroid treatment in sarcoidosis

J. C. Grutters et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Article Critical Care Medicine

The sarcoidosis health questionnaire - A new measure of health-related quality of life

CE Cox et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Review Medicine, General & Internal

Corticosteroid therapy in pulmonary sarcoidosis - A systematic review

S Paramothayan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)

Article Critical Care Medicine

Early treatment of stage II sarcoidosis improves 5-year pulmonary function

A Pietinalho et al.